Human studies are also needed to determine if TNBC’s with activation of the MAPK/RSK pathway have high LDLR expression and are particularly susceptible to the tumor promoting effects of hypercholesterolemia. The gene discussed is RPS6KA3; the disease is Hypercholesterolemia.